HAVAU - NASDAQ
Harvard Ave Acquisition Corporation Unit
$10.22
-0.54%Harvard Ave Acquisition Corporation focuses on effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or similar business combination with one or more businesses or entities. The company was incorporated in 2024 and is based in Seoul, South Korea. Harvard Ave Acquisition Corporation operates as a subsidiary of Copley Square Sponsor Limited.
At a Glance
Live Snapshothavau
Total Current Liabilities
Last Annual Value
473.94K
3-Year CAGR
20%
5-Year CAGR
11%
10-Year CAGR
6%
Harvard Ave Acquisition Corporation Unit Competitors Analysis of Total Current Liabilities
| Company | Total Current Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
 Harvard Ave Acquisition Corporation Unit NASDAQ:HAVAU | 473.94K | N/A | N/A | N/A | |
 Aimei Health Technology Co., Ltd NASDAQ:AFJK | 3.37M | 413.9% | N/A | N/A | |
 BEST SPAC I Acquisition Corp. NASDAQ:BSAA | 152.97K | N/A | N/A | N/A | |
1.98M | 68.6% | N/A | N/A | ||
 Central Plains Bancshares, Inc. Common Stock NASDAQ:CPBI | 0.00 | N/A | N/A | N/A |
Harvard Ave Acquisition Corporation Unit Fair Value Envelope
Related Guides
Continue your HAVAU research with focused valuation guides.
Research Paths
Snapshot
Start with context, operating signals, and key market metrics.
Value Model
Stress test fair value across bear, base, and bull assumptions.
Statements
Validate revenue quality, margins, and balance sheet durability.
Earnings Call
Read management commentary and compare it with reported outcomes.
Dividends
Check payout sustainability and long-term distribution behavior.
Analyst Expectations
Review consensus spread and where estimate risk is concentrated.